PM
XGN icon

Penbrook Management’s Exagen XGN Stock Holding History

Penbrook Management’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$40K Sell
13,330
-100
-0.7% -$387 0.03% 93
2025
Q4 		$81.7K Sell
13,430
-6,480
-33% -$59K 0.06% 95
2025
Q3 		$219K Sell
19,910
-39,365
-66% -$349K 0.15% 87
2025
Q2 		$280K Buy
59,275
+19,910
+51% +$121K 0.11% 96
2025
Q1 		$141K Sell
39,365
-5,229
-12% -$19.7K 0.11% 100
2024
Q4 		$183K Sell
44,594
-18,361
-29% -$66.2K 0.12% 100
2024
Q3 		$195K Sell
62,955
-6,500
-9% -$16.8K 0.13% 96
2024
Q2 		$126K Sell
69,455
-7,255
-9% -$12.3K 0.08% 98
2024
Q1 		$122K Buy
76,710
+1,000
+1% +$1.94K 0.08% 101
2023
Q4 		$151K Buy
75,710
+2,300
+3% +$3.98K 0.1% 96
2023
Q3 		$178K Sell
73,410
-600
-0.8% -$1.52K 0.13% 91
2023
Q2 		$215K Hold
74,010
– – 0.16% 88
2023
Q1 		$180K Hold
74,010
– – 0.14% 89
2022
Q4 		$178K Sell
74,010
-12,990
-15% -$33.3K 0.15% 89
2022
Q3 		$236K Sell
87,000
-1,100
-1% -$6.14K 0.2% 85
2022
Q2 		$506K Sell
88,100
-500
-0.6% -$2.91K 0.4% 66
2022
Q1 		$711K Hold
88,600
– – 0.46% 62
2021
Q4 		$1.03M Buy
88,600
+850
+1% +$9.96K 0.62% 49
2021
Q3 		$1.19M Buy
+87,750
New +$1.17M 0.74% 47

Other funds holding XGN

Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return

Penbrook Management's XGN Position: Q1 2026 in Review

Penbrook Management reduced its Exagen (XGN) stake by 0.74% in Q1 2026, selling an estimated $387 and leaving 13,330 shares worth $40K. The position accounts for 0.03% of the portfolio, ranked #93.

Penbrook Management first reported a position in XGN in Q3 2021 and has held it in 19 quarters since. The position peaked at $1.19M in Q3 2021. 61 funds tracked by Wall St. Rank hold XGN as of Q1 2026.

  • Penbrook Management held 13,330 shares of Exagen worth $40K as of Q1 2026.
  • Penbrook Management sold 100 Exagen shares in Q1 2026, an estimated $387.
  • Exagen made up 0.03% of Penbrook Management's portfolio in Q1 2026, its #93 holding.
  • Penbrook Management first reported a position in Exagen in Q3 2021 and has held it in 19 quarters since.
  • Penbrook Management's Exagen position peaked at $1.19M in Q3 2021.
  • 61 funds tracked by Wall St. Rank held Exagen as of Q1 2026.

Based on Penbrook Management's 13F filing for Q1 2026, filed 21 Apr 2026.